CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress

ConferenceMAIA-ovarianNeutral
AI Analysis

Summary

Compugen presented a trial-in-progress poster on the MAIA-ovarian adaptive platform trial at the ESMO Gynaecological Cancers Congress.

Clinical Trial Data

Importance:2/10
Sentiment:
0.00
conference presentationadaptive trialovarian cancerESMO
Related Companies

Read the original article

Published by yahoo_finance on June 18, 2026 11:00 AM

Read Original